Trulicity, Ozempic, and Victoza. 4 Additional A1c reduction not as significant as weight reduction at higher doses. Drug. Frequency. Equivalent Dose (A1c
Ozempic outperformed Trulicity in reducing A1C Ozempic delivered superior A1C control vs Trulicity Ozempic demonstrated superior body weight reduction vs
In the SUSTAIN 7 trial, Ozempic was proven superior to Trulicity in A1C reduction, A1C control, and weight reduction in adults with type 2 diabetes.1 Ozempic
In the SUSTAIN 7 trial, Ozempic was proven superior to Trulicity in A1C reduction, A1C control, and weight reduction in adults with type 2 diabetes.1 Ozempic
After 26 weeks, both doses of Trulicity were superior to Lantus in A1C reduction, and significantly more patients reached the recommended A1C target of less than 7 percent. A1C reductions from baseline: -1.7 percent (Trulicity 1.5 mg), -1.32 percent (Trulicity 0.75 mg), -1.15 percent (Lantus).
In the SUSTAIN 7 trial, Ozempic was proven superior to Trulicity in A1C reduction, A1C control, and weight reduction in adults with type 2 diabetes.1 Ozempic
In the SUSTAIN 7 trial, Ozempic was proven superior to Trulicity in A1C reduction, A1C control, and weight reduction in adults with type 2 diabetes.1 Ozempic
Trulicity, Ozempic, and Victoza. 4 Additional A1c reduction not as significant as weight reduction at higher doses. Drug. Frequency. Equivalent Dose (A1c
Trulicity, Ozempic, and Victoza. 4 Additional A1c reduction not as significant as weight reduction at higher doses. Drug. Frequency. Equivalent Dose (A1c
Comments